Companies: 49,246 Total Market Cap: 132386205533959.40

Square Pharmaceuticals PLC.

DSE-SQURPHARMA
Pharmaceutical Preparations
Rank #7189
Market Cap 1.51 B
Volume 121,966
Price 1.70
Change (%) 0.24%
Country or region Bangladesh Bangladesh

Square Pharmaceuticals PLC.'s latest marketcap:

1.51 B

As of 05/20/2025, Square Pharmaceuticals PLC.'s market capitalization has reached $1.51 B. According to our data, Square Pharmaceuticals PLC. is the 7189th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.51 B
Revenue (ttm) 616.21 M
Net Income (ttm) 190.92 M
Shares Out 886.45 M
EPS (ttm) 0.22
Forward PE 7.76
Ex-Dividend Date 11/24/2024
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/20/2025

Square Pharmaceuticals PLC.'s yearly market capitalization.

Square Pharmaceuticals PLC. has seen its market value drop from 194.58 B BDT to 186.15 B BDT since 2020, representing a total decrease of 4.33% and an annual compound decline rate (CAGR) of 1.00%.
Date Market Cap(BDT) Change (%)
05/20/2025 186.15 B -4.13%
12/30/2024 192.98 B 3.52%
12/28/2023 186.42 B 0.24%
12/29/2022 185.98 B -2.1%
12/30/2021 189.97 B -2.37%
12/30/2020 194.58 B

Company Profile

About Square Pharmaceuticals PLC.

Square Pharmaceuticals PLC., along with its subsidiaries, is a leading manufacturer and marketer of pharmaceutical products, serving both Bangladesh and international markets.

Product Portfolio

  • Pharmaceuticals: Includes a wide range of treatments such as:
    • Analgesics, anti-ulcerants, antibiotics, antidiabetics, and antifungals
    • Cardiovascular, CNS, and respiratory medications
    • Vitamins, steroids, and non-steroidal anti-inflammatory drugs (NSAIDs)
    • Oncology, hepatobiliary, and urological preparations
  • Specialty Products:
    • Generic pharmaceuticals, infusions, and mouthwash
    • Herbal and nutraceutical products
    • Reusable insulin pens (AnsuPen brand)
  • Agricultural & Animal Health: Crop care chemicals, insecticides, and veterinary products

Global Reach

The company exports its products to 42 countries, reinforcing its presence in international markets.

Corporate Background

Founded in 1958 and headquartered in Dhaka, Bangladesh, Square Pharmaceuticals PLC. operates as a subsidiary of Square Group.

Frequently Asked Questions

As of 05/20/2025, Square Pharmaceuticals PLC. (including the parent company, if applicable) has an estimated market capitalization of $1.51 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Square Pharmaceuticals PLC. global market capitalization ranking is approximately 7189 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bangladesh
Founded 1958
IPO Date n/a
Employees 12,453
CEO Tapan Chowdhury
Sector
Industry Pharmaceutical Preparations
Address Square Centre
Dhaka, 1212
Bangladesh
Website https://www.squarepharma.com.bd
People Also Watch
Ipsen S.A.
138.21 0.24%
Krka, d. d.
209.75 0.24%
BUD-RICHTER
29.11 0.24%
Hugel
244.93 0.24%